Patent details

EP3473270 Title: ANTIBODY-DRUG CONJUGATE

Basic Information

Publication number:
EP3473270
PCT Application Number:
JP2017022509
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178153516
PCT Publication Number:
WO2017221883
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY-DRUG CONJUGATE
French Title of Invention:
CONJUGUÉ ANTICORPS-MÉDICAMENT
German Title of Invention:
ANTIKÖRPER-WIRKSTOFF-KONJUGAT
SPC Number:

Dates

Filing date:
19/06/2017
Grant date:
30/11/2022
EP Publication Date:
24/04/2019
PCT Publication Date:
28/12/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/11/2022
EP B1 Publication Date:
30/11/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/06/2023
Expiration date:
19/06/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/11/2022
 
 

Name:
GenAhead Bio, Inc.
Address:
26-1, Muraoka-Higashi 2-chome, Fujisawa-shi Kanagawa 251-0012, Japan (JP)

Inventor

1

Name:
SUGO, Tsukasa
Address:
Japan (JP)

2

Name:
OHTAKI, Tetsuya
Address:
Japan (JP)

3

Name:
MIYATA, Kenichi
Address:
Japan (JP)

Priority

Priority Number:
2016122187
Priority Date:
20/06/2016
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 39/395; A61K 31/7088; A61K 31/7105; A61K 45/00; A61K 48/00; A61P 9/00; A61P 21/00; A61K 47/68; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202248
Publication date:
30/11/2022
Description:
Grant (B1)

2

Issue number:
202301
Publication date:
04/01/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages